RecruitingNCT07244237

Assessing Spinal Pain With an Artificial Intelligence-assisted Whole Body Electrical Stimulation Device

Validity of an AI-Supported Whole-Body Electrical Stimulation Device for Spinal Pain Assessment: A Comparison With Self-Reported Pain Scores


Sponsor

Amasya University

Enrollment

200 participants

Start Date

Nov 15, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to investigate the correlation between self-reported pain and the measurements obtained using an artificial intelligence-assisted whole-body electrical stimulation device (StimaWELL 120MTRS system) in individuals with chronic back pain. The main question it aims to answer is: Is there any correlation between the pain intensity assessed with StimaWELL 120MTRS system, dolorimeter and self-report in adults with chronic back pain? The patients who have back pain for the duration longer than 3 months and have been eximaned by a medical doctor will be assessed with StimaWELL 120MTRS system, dolorimeter, and will be asked to rate their pain intensity in Numerical Pain Rating Scale.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Inclusion Criteria7

  • Experiencing back pain for more than three months
  • Experiencing recurrent back pain over the last week
  • Not having used analgesic or muscle relaxant medications in the last week
  • Aged between 18 and 60 years
  • Diagnosed with chronic low back pain by a medical doctor
  • Literate and able to cooperate with study procedures
  • Willing to participate in the study

Exclusion Criteria12

  • Having neurological, inflammatory, radiculopathy, vertebral fracture, or similar conditions
  • Experiencing acute-onset pain
  • Being pregnant or at risk of pregnancy
  • Having a psychiatric diagnosis and currently taking medication
  • Having a skin disease or lesion in the area where electrodes will be applied
  • Currently undergoing physical therapy
  • Having vestibular, auditory, or cognitive impairments
  • Possessing an electronic implant
  • Having a cardiac arrhythmia
  • Having a coronary or carotid stent
  • Being diagnosed with epilepsy
  • Having severe osteoporosis of the spine

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

AMASYAŞAM Sağlıklı Yaşam Merkezi

Amasya, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07244237


Related Trials